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Microcephaly is the clinical finding of a head circumfer-ence measurement greater than three standard devia-tions (SD) below the population mean for age and sex.
It is usually accompanied by mental retardation and there are
many diagnoses with both environmental and genetic
aetiologies.1 Autosomal recessive primary microcephaly
(MCPH) (MIM 251200) is a disorder in which affected subjects
are born with a small head circumference, explained by a
cerebral cortex of reduced size, and are mentally retarded. The
brain is structurally normal and, apart from the intellectual
impairment, there are no other significant neurological prob-
lems, dysmorphic features, or malformations.2 3 In a study
carried out in The Netherlands,4 the incidence of MCPH was
approximately 1/250 000 but it is probably greater in popula-
tions with a high rate of consanguineous marriages. MCPH has
been shown to be genetically heterogeneous with the identifica-
tion of five loci: MCPH1 on 8p23,5 MCPH2 on 19q13,6 MCPH3 on
9q34,7 MCPH4 on 15q15-q21,8 and MCPH5 on 1q31.9 10 MCPH1,
2, and 3 were mapped in northern Pakistani families, MCPH4 in
a Moroccan family, and MCPH5 in northern Pakistani and
Turkish families. Here we report the identification by autozygos-
ity mapping11 of a novel locus for primary microcephaly,
MCPH6, in a north eastern Brazilian family.
MATERIALS AND METHODS
Subjects
The consanguineous family had eight affected subjects (five
males and three females, DNA available from seven subjects),
with ages varying between 4 and 27 years (fig 1), in four sib-
ships (fig 2). The head circumference of all affected subjects
was noted to be small at birth and between 7-10 SD below the
expected mean when examined by us. All had mental
retardation of moderate severity: the three adults and the
adolescent affected were unable to read or write but could
speak simple phrases and had basic self-care skills. With the
exception of intellectual impairment, there were no other
neurological problems (including fits) and motor develop-
ment had been normal. All eight were in good health and had
growth parameters within normal limits. They were not dys-
morphic and no syndrome diagnosis could be made. No past
medical history or environmental causes could be found to
explain the finding of microcephaly. The parents had normal
head circumference and intelligence. Ophthalmological
examination, standard lymphocyte karyotype (400 bands),
and electroencephalogram performed in four affected sub-
jects were normal, and brain scans in two showed no cerebral
malformations or neuronal ectopia.
Molecular genetics
Linkage to the five known MCPH loci was ruled out (data not
shown). An autosomal chromosome screen for regions of
shared homozygosity was performed on seven of the eight
Figure 1 Six of the eight affected subjects with ages between 4 and 27 years with a diagnosis of autosomal recessive primary microcephaly.
Key points
• Autosomal recessive primary microcephaly (MCPH) is a
genetic disorder in which an affected subject is born
with a head circumference >3 SD below the expected
mean and is mentally retarded.
• We report a novel locus (MCPH6) mapped to chromo-
some 13q12.2 in a Brazilian family.
• The minimal critical region spans 6 Mb between mark-
ers AL139378GT17 and D13S1244 with a maximum
two point lod score of 6.25.
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affected subjects and their parents with the CHLC/Weber
Human Screening Set version 8 (Research Genetics), which
contains 365 autosomal microsatellite repeat markers spaced
at approximately 10 cM intervals. PCR amplification of all
markers was performed according to the manufacturer’s
specifications using a Roboseq 4200 (MWG BioTech Ltd).
Amplified markers were pooled and electrophoresed on an
ABI Prism 377 gene sequencer (Applied Biosystems) on 4.2%
polyacrylamide gels, at 3000 V and 52°C, for 2.5 hours.
Fragment length analysis was undertaken using the ABI
Prism Genescan and Genotyper 1.1.1 analysis packages.
RESULTS
A single region of homozygosity common to all seven
microcephalic subjects was identified on chromosome 13q
defined by markers D13S787 and D13S1304. Further refine-
ment of the region was conducted using the following mark-
ers selected from the ABI Linkage Mapping Panel Version I
(Applied Biosystems), the Todd Panel,12 and the Marshfield
Linkage Maps: cen - D13S175 - D13S1275 - D13S787 -
D13S221 - D13S1304 - D13S1254 - D13S1244 - D13S217 -
D13S120 - D13S171 - D13S1493 - tel. This defined a shared
homozygous region on chromosome 13 at band q12.2 with
meiotic crossovers between markers D13S175-D13S1275 and
D13S1254-D13S1244, with the centromeric and telomeric
boundaries of a 9 cM region being defined by D13S175 and
D13S1244. Information regarding marker order and relative
distances was obtained from the Marshfield Linkage Maps.
The marker order obtained from the Marshfield Linkage Maps
was in agreement with that derived from analysis of the cur-
rent draft human genome data.
A fully penetrant autosomal recessive mode of inheritance
and a disease gene frequency of 0.003 were assumed. Owing to
the complexity of the family structure, equal allele frequencies
Figure 2 Genotypes for eight markers used in the study at 13q12.2 arranged centromere to qter. Unaffected sibs have been omitted for
clarity. Marker order was taken from the Marshfield linkage map. The boxed region shows the shared region of homozygosity in affected
subjects. The FGF9 gene, indicated by an arrow, is flanked by markers AL139378GT21 and AL139378GT17 and hence is excluded as a
candidate gene from the common homozygous region in affected subjects.
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were assumed for each marker when calculating the lod scores
and the maximum number of alleles was set at 4. Pedigree
allele inconsistencies were identified using PedCheck.13 Two
point analysis was performed using the LINKAGE analysis
programs14 at θ=0 for markers in the critical region and results
are shown in table 1 with the highest lod score at 6.25 for
marker D13S1275.
Novel microsatellite markers to refine the region further
were designed using the Human Genome Browser and the
Primer3 program, and designated [human BAC accession
number][microsatellite repeat unit][number of unit repeats
in the reference BAC], for example, AL356285TG25 (fig 2).
These allowed us to redefine the centromeric boundary
marker as AL139378GT17.
DISCUSSION
Haplotype and lod score analysis both suggest that the
chromosome region 13q12.2, designated the MCPH6 locus,
contains a gene which when mutated causes autosomal reces-
sive primary microcephaly.
Within the larger MCPH6 region of 9 cM there is the poten-
tial candidate gene, fibroblast growth factor 9 (FGF9). In the
nervous system of mice, FGF9 is produced mainly by neurones
and may have a role in glial cell growth and differentiation
during development.15 16 The redefinition of the region to 6 cM
using novel microsatellite markers flanking FGF9 resulted in
the exclusion of this gene (fig 2). We now therefore consider
that the gene causing this form of autosomal recessive
primary microcephaly must lie within this smaller region of
approximately 6 Mb. To date, only the MCPH1 gene,
microcephalin, and the MCPH5 gene, ASPM, have been
identified.17 18 Future identification of the MCPH6 gene may be
aided by an insight into how these proteins function and
interact within the human brain, such as mitotic spindle
activity in the case of ASPM. The discovery of MCPH genes will
lead to a greater understanding of normal and abnormal
human fetal cerebral cortex growth, giving potential insights
into the question of how the mammalian cerebral cortex
evolved and has become so predominant in humans, and the
wherewithal to offer diagnostic, prenatal, and carrier testing
for affected families.
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Table 1 Two point lod scores at θ=0
for each marker defining the MCPH6
region at 13q12.2
Marker Lod score at θ = 0
D13S175 −∞
D13S1275 6.25
D13S787 5.90
D13S221 3.87
D13S1304 2.75
D13S1254 4.29
D13S1244 2.31
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